Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Adherence to a Raltegravir-based Antiretroviral Regimen for HIV Non-occupational Postexposure Prophylaxis

NCT01087840 is registered in ClinicalTrials.gov with Andrew Carr as lead sponsor.

NCT NCT01087840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01087840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Adherence to a Raltegravir-based Antiretroviral Regimen for HIV Non-occupational Postexposure Prophylaxis
Lead sponsor
Andrew Carr
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2010
Completion date
July 31, 2012
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hiv prevention